Unlocking
the future
of medicine

About us

Offering an unrivalled modular platform and tailored hyper-targeting is how we stand apart

Pipeline

Reducing the impact of cancer and autoimmune diseases on people’s lives is why we’re here

Innovation and research

Pushing the boundaries of human advancement in medicine is what drives us every day

Investors
 
 
 

A vaccine platform that unlocks unlimited possibilities for the future of medicine

The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.

Highlights

Nykode Therapeutics – invitation to Q3 2024 financial results ...

Read More
20 November 2024

Nykode Therapeutics VB10.NEO update – presentation

Read More
08 November 2024

Nykode Therapeutics – Webcast Invitation

Read More
07 November 2024

Nykode Therapeutics to Regain Control of VB10.NEO Program

Read More
07 November 2024

Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform ...

Read More
06 November 2024

Nykode Therapeutics – Q2 2024 Financial Results – presentation

Read More
21 August 2024

Nykode Therapeutics reports Q2 2024 Financial Results

Read More
21 August 2024

Nykode Therapeutics Announces Strategic Repositioning of VB10.16 to Focus ...

Read More
21 August 2024

Nykode Therapeutics Announces Issuance of Key Patent Covering Individualized ...

Read More
14 August 2024